ZBTB24 Inhibitors
Chemical inhibitors of ZBTB24 can exert their effects through various cellular mechanisms that impede the protein's function indirectly. Chloroquine, by increasing the pH of acidic vesicles, disrupts lysosomal function, which is essential for the breakdown of proteins. This disruption can lead to an inadvertent increase in ZBTB24 levels due to a reduction in its degradation. Similarly, Bafilomycin A1 targets the V-ATPase proton pump, crucial for the acidification of organelles such as lysosomes, leading to a comparable outcome as that observed with Chloroquine. In the case of MG132, by inhibiting the proteasome pathway, it prevents the degradation of ubiquitinated proteins, resulting in the accumulation of proteins within the cell which may include ZBTB24, thereby affecting its functional integrity.
Further influencing ZBTB24, Oligomycin acts on mitochondrial ATP synthase, reducing ATP production, which is vital for numerous cellular processes, including protein folding and function. Consequently, this energy deprivation can impair the proper functioning of ZBTB24. Monensin, by altering pH levels and ion gradients within the Golgi apparatus, can impair protein trafficking and glycosylation, processes that are essential for the correct functioning of various proteins, including ZBTB24. Additionally, 2-Deoxy-D-glucose, as a glycolysis inhibitor, impedes the primary energy production pathway, which is likely to decrease cellular function and indirectly affect energy-dependent proteins such as ZBTB24. Alisertib, which inhibits Aurora kinase A, affects cell cycle progression; this disruption can lead to altered levels of proteins associated with the cell cycle, possibly including ZBTB24. Lastly, Paclitaxel, by stabilizing microtubules and preventing their disassembly, inhibits cell division, which can result in a decrease in the production and function of cell cycle-regulated proteins like ZBTB24.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to raise the pH of acidic vesicles within cells, which can disrupt lysosome function. Lysosomes are involved in the degradation of proteins, and by impairing lysosomal function, Chloroquine can inhibit the degradation of ZBTB24, indirectly maintaining its functional presence within the cell. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
This compound inhibits Topoisomerase I, an enzyme that relieves torsional stress in DNA during DNA replication. By inhibiting this enzyme, Camptothecin can indirectly inhibit the replication of cells with active ZBTB24, leading to a reduction in the overall levels of ZBTB24 as cell division is a key process for protein propagation. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
As an inhibitor of the V-ATPase proton pump, Bafilomycin A1 prevents the acidification of organelles like lysosomes. This inhibition can result in reduced lysosomal degradation of proteins, indirectly maintaining higher levels of ZBTB24 within the cell. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Oligomycin acts as an inhibitor of ATP synthase in mitochondria, leading to reduced ATP production. Since ATP is required for many cellular processes including the proper folding and function of proteins, this can indirectly lead to a functional inhibition of ZBTB24 due to energy deprivation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that prevents the degradation of ubiquitinated proteins. By inhibiting this pathway, MG132 can lead to an accumulation of misfolded or damaged proteins, which can exert a dominant negative effect on related proteins, potentially including ZBTB24. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, which is involved in the activation of T-cells. As ZBTB24 has been implicated in immune function, inhibiting a key regulatory pathway of immune activation can indirectly lead to the functional inhibition of ZBTB24. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin disrupts Golgi function by altering pH levels and ion gradients. This can inhibit proper protein trafficking and glycosylation, processes that are vital for the function of many proteins, potentially including ZBTB24. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog inhibits glycolysis by blocking hexokinase. By impeding the primary energy production pathway, this can lead to decreased overall cellular function and indirectly inhibit proteins that require significant energy to maintain their function, including ZBTB24. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Alisertib is an Aurora kinase A inhibitor. Aurora kinase A is involved in cell cycle progression, and by inhibiting this kinase, Alisertib can disrupt normal cell cycle, which could indirectly lead to decreased levels of cell cycle-related proteins, including ZBTB24. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
ABT-199 is a Bcl-2 inhibitor that promotes apoptosis in cancer cells. As apoptosis is a regulated process involving numerous proteins, inhibiting a key regulatory protein like Bcl-2 can affect other proteins involved in cell survival, potentially including ZBTB24. | ||||||